A simple questionnaire to enable people with MS to come better prepared for their consultations.
- Optimises consultation structure and efficiency
- Developed with multiple sclerosis (MS) experts and patients with MS
Why use the YourMS questionnaire?
Tracking MS symptoms over time can be challenging
- Patient input is essential in identifying changes in MS1
- Objective assessment and structure in monitoring MS symptoms can lead to improvements in recognising the subtle signs of worsening MS2
Monitoring changes in MS symptoms is critical in identifying the most appropriate management approach.3 HCPs typically rely on:
Taking patient histories
Testing for changes in ability
What is the YourMS questionnaire?
A questionnaire that encourages patients to reflect on their MS
- A set of clinically relevant questions help patients to assess their MS symptoms over the previous 6 months
- Patients complete the questionnaire in the comfort of their home
- The user-friendly interface was developed with MS patients in mind, is easy to complete and uses patient-friendly language
What are the benefits of using the YourMS questionnaire?
Each person’s MS is unique; therefore, YourMS questionnaire:
Enables patients with MS to come prepared for their consultations
Enables focussed conversations and increased patient engagement throughout the disease course
Encourages patients to reflect on their MS symptoms
Helps patients take control of their MS
What do other healthcare professionals (HCPs) think of YourMS?
Proportion of HCPs who ‘strongly agree’ or ‘agree’:
It was useful to my face-to-face or remote consultations with my patients to have the patient questionnaire completed4
The use of the questionnaire was helpful in making my patients more engaged in their MS4
The use of the patient questionnaire positively influenced my clinical practice4
HCP, healthcare professional; MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis.
- Inojosa H, et al. J Neurol. 2019;268:1210–1221.
- Davies F, et al. Int J MS Care. 2016;18:257–264.
- Gross HJ, Watson C. Neuropsychiatr Dis Treat. 2017;13:1349–1357.
- Ziemssen T, et al. Oral session: DXM01. Presentation at Consortium of Multiple Sclerosis Centers Annual Meeting, October 28 2021, Orlando, Florida.